Private and public health collaboration brings hope to 15 Limpopo boys
Drickus Maartens • December 4, 2019
Initiative succeeds in simultaneously training doctors and treating deserving children
A collaboration between the private and public health sectors in Limpopo has not only brought to fruition a project in which 15 boys from indigent families in the province benefitted from a free surgical procedure but has also served as a training opportunity for local doctors.
Organised by paediatric and neonatal surgeon, Dr Elliot Motloung, and hosted by Netcare Pholoso Hospital in Polokwane on 28 and 29 November, the minimally invasive Fowler-Stephens procedure to reposition undescended testes that cannot be detected by a routine medical examination alone was demonstrated live to paediatric surgeons and urologists. This condition is known in medical terms as non-palpable undescended testes.
The project, which was made possible by a collaboration between Netcare Pholoso Hospital, the Netcare Foundation and Mankweng Hospital, simultaneously enabled all 15 boys to benefit from the procedure, which was done for free.
“When I returned to Limpopo recently to practice in the province, I noted that cases of boys born with non-palpable undescended testes were often being referred to Gauteng hospitals for treatment,” says Dr Motloung, who is the director of paediatric surgical services at both Mankweng and Polokwane hospitals, and a senior lecturer at the University of Limpopo School of Medicine. He also practises at Netcare Pholoso Hospital.
“Given that these boys could well develop complications from the condition and that between 4% and 10% of boys whose undescended testes go untreated will develop testicular cancer, I thought that it was critical to find ways to address this challenge within the province. An educational symposium that both met the need of training local medical practitioners in the diagnosis and treatment of the condition, while at the same time providing free treatment locally to these young patients, struck me as a sound starting point,” he adds.
The 15 laparoscopic, or minimally invasive, procedures were conducted by Dr Motloung and three other highly experienced laparoscopic surgeons, namely Dr Hansraj Mangray, Dr Martin Phakula, and Dr Y Hawu, over the two days. Dr Motloung says that the training symposium, which was accredited as a continuing professional development (CPD) event, was the first of its kind to be held in Limpopo and was a great success, with a number of doctors who attended the first day having expressed their appreciation of the opportunity. MEC for the Limpopo Department of Health, Phophi Ramathuba, visited the hospital and patient wards while the symposium was in progress.
“Netcare Pholoso Hospital and the Netcare Foundation covered the theatre, hospital and other costs associated with the 15 procedures and sponsored the symposium. The initiative was also well supported by medical product and equipment suppliers,” says the hospital’s general manager, Fabion Bennett.
According to Dr Motloung, when a male baby develops in the womb its testicles form in the abdomen and then usually descend into the scrotum shortly before birth. However, in some babies either one or both of the testicles fail to descend into the scrotum before birth, a condition called cryptorchidism.
“In such cases the testicle may remain in the abdomen or only partially descend into the groin area. It is not fully understood what causes cryptorchidism, but it is one of the most common disorders of the genitals in male newborns. Some 20% of these babies will most probably need surgery to reposition the testes, and this should be done at an early age for the best results,” he explains.
“The children who underwent the free procedure were all referred to me for medical examination and investigation, ultrasound study and blood work at Mankweng Hospital. The patients were all prepared for surgery at Mankweng Hospital before being transferred to Netcare Pholoso Hospital
for the procedure.
“We used a Fowler-Stephens laparoscopic procedure, guided by a tiny camera, to treat the condition in the children. It takes approximately 30 minutes to reposition the testes from the abdomen and into the scrotum, using this minimally invasive ‘keyhole’ procedure,” explains Dr Motloung.
“We are most grateful to Dr Motloung for driving this remarkable project, which is an excellent example of the possibilities of public private collaboration for the benefit of the patient,” says Jacques du Plessis, managing director of the Netcare hospital division.
“Netcare is proud to have been associated with this initiative, which demonstrates how the public and private healthcare sectors can join hands, together with dedicated medical practitioners, to meaningfully tackle health challenges affecting our children,” concludes Du Plessis.
About Dr Elliot Motloung
Dr Elliot Motloung completed his undergraduate medical degree at the University of the Free State in 2007. He did his internship at Ladysmith Provincial Hospital in KwaZulu-Natal and Boitumelo Provincial Hospital in the Free State, and thereafter enrolled with the South African Military Health Services to do his community service at the SA Military School of Engineering in 2010.
In 2011, Dr Motloung commenced working in the Department of Paediatric Surgery at the East London Hospital complex, before commencing his registrar’s training programme in paediatric surgery at the University of the Free State in 2013.
Dr Motloung has a particular interest is in minimally invasive thoraco-abdominal surgery and paediatric trauma and is currently the director of Paediatric Surgical Services at both Mankweng and Polokwane hospitals, as well as a senior lecturer at the University of Limpopo School of Medicine. Dr Motloung also practises at Netcare Pholoso Hospital.
Migraines affect 15% of the global population, causing severe pain and disrupting daily life. Neurologist Dr. Michael Huth emphasises the importance of understanding different migraine types and their triggers.
Dr Michael de Villiers explains why people can become sick every flu season and why the influenza vaccine is generally recommended every year.
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
